These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 26692196)
21. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice. Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958 [TBL] [Abstract][Full Text] [Related]
22. Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization. Schepers K; Fibbe WE Ann N Y Acad Sci; 2016 Apr; 1370(1):15-23. PubMed ID: 26713608 [TBL] [Abstract][Full Text] [Related]
23. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease. Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134 [TBL] [Abstract][Full Text] [Related]
24. Potential Use of Mesenchymal Multipotent Cells for Hemopoietic Stem Cell Transplantation: Pro and Contra. Kiselevskiy M; Vlasenko R; Reshetnikova V; Chikileva I; Shubina I; Osmanov E; Valiev T; Sidorova N; Batmanova N; Stepanyan N; Kirgizov K; Varfolomeeva S J Pediatr Hematol Oncol; 2021 Apr; 43(3):90-94. PubMed ID: 33560076 [TBL] [Abstract][Full Text] [Related]
25. Potential therapeutic applications of mesenchymal stromal cells. Larsen S; Lewis ID Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470 [TBL] [Abstract][Full Text] [Related]
26. [Mesenchymal stromal cells in the treatment of graft-versus-host disease: where do we stand?]. Schüle S; Berger A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov; 58(11-12):1265-73. PubMed ID: 26369762 [TBL] [Abstract][Full Text] [Related]
27. Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence. Rizk M; Monaghan M; Shorr R; Kekre N; Bredeson CN; Allan DS Biol Blood Marrow Transplant; 2016 Aug; 22(8):1416-1423. PubMed ID: 27130504 [TBL] [Abstract][Full Text] [Related]
28. The Potential of Mesenchymal Stromal Cells as Treatment for Severe Steroid-Refractory Acute Graft-Versus-Host Disease: A Critical Review of the Literature. Munneke JM; Spruit MJ; Cornelissen AS; van Hoeven V; Voermans C; Hazenberg MD Transplantation; 2016 Nov; 100(11):2309-2314. PubMed ID: 26714122 [TBL] [Abstract][Full Text] [Related]
29. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease. Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216 [TBL] [Abstract][Full Text] [Related]
30. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD? Introna M; Golay J Front Immunol; 2020; 11():609063. PubMed ID: 33362797 [TBL] [Abstract][Full Text] [Related]
31. Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease. Keshavarz Shahbaz S; Mansourabadi AH; Jafari D Clin Exp Immunol; 2022 May; 208(1):12-24. PubMed ID: 35274673 [TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. Kim N; Im KI; Lim JY; Jeon EJ; Nam YS; Kim EJ; Cho SG Ann Hematol; 2013 Oct; 92(10):1295-308. PubMed ID: 23722500 [TBL] [Abstract][Full Text] [Related]
37. CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect. Li H; Jiang Y; Jiang X; Guo X; Ning H; Li Y; Liao L; Yao H; Wang X; Liu Y; Zhang Y; Chen H; Mao N Stem Cells; 2014 Jul; 32(7):1890-903. PubMed ID: 24496849 [TBL] [Abstract][Full Text] [Related]
38. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease. Jang YK; Kim M; Lee YH; Oh W; Yang YS; Choi SJ Cytotherapy; 2014 Mar; 16(3):298-308. PubMed ID: 24418403 [TBL] [Abstract][Full Text] [Related]
39. The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation. Zhao K; Liu Q J Hematol Oncol; 2016 May; 9(1):46. PubMed ID: 27193054 [TBL] [Abstract][Full Text] [Related]
40. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity. Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]